Total Return chart Alkermes plc

Stocks

Market Closed - Nasdaq 00:00:00 03/10/2026 +04			5-day change	1st Jan Change
41.75 ^USD	+2.98%		+2.20%	+49.21%

09-22	Alkermes ADHD Data Boosts Confidence in ALKS7290, Orexin Pipeline, RBC Says	MT
09-21	Alkermes Plc Announces Positive Phase 1b Results Demonstrating Clinical Proof-Of-Concept For ALKS 7290 In Adults With Attention-Deficit Hyperactivity Disorder	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.